12 th International Congress on Psychopharmacology and 8th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Türkiye, 17 - 20 Kasım 2021, ss.26-29
ICP 2021 Outstanding Research Award Nominees Brief Reports
0369 - Effects of metformin on learning and memory functions of young and aged rats
Ozgur Baris1-2, Semil Selcen Gocmez1, Ipek Komsuoglu Celikyurt1, Tijen Utkan1
1: Kocaeli University Faculty of Medicine, Department of Pharmacology, Kocaeli, Turkey., 2: Kocaeli University Faculty of Medicine, Department of Cardiovascular Surgery, Kocaeli, Turkey
BRIEF REPORT |
METHODS: Wistar-Albino male rats were separated into four groups: young mice (<12months-old), young mice +metformin, aged mice (24 months old), aged mice+ metformin. Metformin (100mg/kg) was supplemented into drinking water for 8 weeks. Morris water maze (MWM) and passive avoidance (PA) tests were used to determine learning and memory functions. Locomotor activity (locomotor activity cabinet system) was measured with a computerized system. Locomotor activity test Passive avoidance test |
2. The acquisition (training) trial was conducted 15 min after pre-acquisition trial. Rats were placed in light compartment, after 30-s adaptation period, door between the compartments were opened. Having completely entered dark compartment, door was automatically closed, and an electric foot-shock (0.5 mA) of 3-s duration was delivered to animal via grid floor. The time taken to reenter dark compartment was recorded (training latency). Any animal failing to cross from the light to dark compartment within 300 s was discarded from the experiment. Animals were then removed from dark compartment and returned to their home cages. Between each training session, both chamber compartments were cleaned to remove any confounding olfactory cues. 3. Retention trial: Recall of inhibitory stimulus was evaluated at 24-h post-training by returning animals to light compartment and recording their latency to enter dark compartment (4 paws in). No foot-shock was applied in this trial. If animal did not enter dark compartment within 300-s, it was returned to its cage and a maximum latency of 300-s was recorded. This latency served as a measure of retention performance of step- down avoidance responses (retention latency). Morris water maze test |
into 4 quadrants. Three equally-spaced points around the edge of pool were used as release positions. Order of release positions was varied systematically throughout the experiment. An escape platform (6-cm in diameter and 12-cm high) was located in 1 quadrant, 1 cm above water surface during familiarization session and 1 cm below water surface during other sessions. Video tracking was conducted with a video camera (Sony Dcr-Hc40e) focused on full diameter of pool. The rats were trained in Morris water maze during 5 daily sessions (familiarization session, S1, S2, S3, and S4). The 5 sessions were performed on consecutive days between 9:00 and 12:00. During acquisition phase of experiments, each rat participated in 3 trials per day. For each daily trial, the rat was taken from home cage and placed into the water maze at 1 of 3 randomly |
26
ICP 2021 Outstanding Research Award Nominees Brief Reports
determined locations with its head facing the center of water maze. A trial was started when rat was released from 1 of 3 randomly chosen start positions. After rat found and climbed onto platform, trial was stopped and escape latency was recorded. Maximum trial length was 60 s. If rat had not climbed onto platform within 60 s, the experimenter guided rat by hand to platform and an escape latency of 60 s was recorded. Inter- trial time was 60 s. During this time, rat was kept on escape platform before starting next trial. Rat was then placed in pool again, but at a different location, and next trial began upon its release. Normally, escape latency declines during acquisition as animal learns the location of hidden platform. At the end of third trial, rat was returned to its cage. Twenty-four hours after last acquisition session, a ‘probe trial’ was used |
to assess rats’ spatial retention of location of hidden platform. During this trial, platform was removed from the maze, and each rat was allowed to search pool for 60 s before being removed. During this trial, animals should spend more time swimming in quadrant that previously contained the hidden platform than in other 3 quadrants. After these tests, according to the guidelines of animal ethics committees, the hippocampus and the cortex of brain tissues was excised after the rats were sacrificed. The effect of senescence related inflammation on the tissues in aging rats was evaluated by PCR gene expression analysis. Histological study was performed for cortex and hippocampus tissues. Statistics |
for data that did not fit the normal distribution. RESULTS: In MWM test, there’s a significant increase in acquisition latency (1-4 days) of 24-month-old rats. In acquisition session of MWM test, in day 1, there’s a significant difference between aged vs young rats. In day 2, there’s a significant difference between aged vs young rats and aged vs (young +met) group. In day 3, there’s a significant difference between aged vs young rats; aged vs (young +met) group and also (aged+met) group vs aged rats. In day 4, there’s a significant difference between (1) aged vs young rats and (2) aged vs (young+Met) and (3) (aged +Met) vs aged rats. In probe trial of MWM test, there’s a significant difference between young vs aged rats. There’s a significant difference between (young+Met) vs aged rats and there’s a significant difference between aged vs (aged+met) group. In probe trial of MWM test, there’s a significant reduction in “time spent in the escape platform’s quadrant” in aged rats compared to young rats. Metformin treatment reversed reduction of “time spent in escape platform’s quadrant” of aged rats. In PA test, there was no significant difference in 1st-day latency of rats in all groups. There’s a significant difference between young vs aged rats and there’s a significant difference between aged vs (aged+Met) group. The locomotor activity of rats was not affected. A regular cerebral cortex was seen with neurons of normal morphology in the young control and young metformin groups. Degenerated neurons, intercellular and perivascular edema were observed in the aged control group. Regenerated neurons were observed with decreased edema in the aged metformin group. Hippocampus (CA2) with regular morphology was observed in the young control and young metformin groups. Degenerated neurons and severe pericellular and perivascular edema were observed in the aged control group, whereas neurons in the aged metformin group showed regeneration close to normal morphology. By PCR gene expression analyses there was very significant results in all metformin groups p<0,001; Ki67 & NF- B & TNF- ➔ hippocampus and cortex |
PDGFR- β & i-NOS➔hippocampus TGF- & IL-6➔cortex DISCUSSION: This study demonstrates that chronic metformin treatment affects learning and memory performance in different learning and memory tasks in aged animals. Memory function may be defined as the ability to acquire, process, store, and retrieve information. We investigated the effects of long-term administration of metformin in passive avoidance and Morris water maze test, finding that metformin improved spatial and emotional learning and memory in distinct behavioral tasks involving different brain structures including hippocampus and amygdala. In our study, we used metformin which beyond its impact on glycemic control, it may have pleotropic effects targeting multiple age-related mechanisms. Previous studies have found that metformin decreases inflammatory markers, NF-κB, ROS and mTOR pathways, thus decreasing DNA damage. Our findings suggest that aging itself, negatively affects spatial and emotional memory functions in rats. Metformin administration might have an affirmative effect on age-related learning and memory dysfunctions. In response to age-related increased inflammatory and |
oxidative stress, the neuroprotective effects seen in metformin groups correlate with learning and memory functions. The statistically significant decrease in inflammatory cytokine levels in hippocampus and cortex tissues with metformin and the increase in the levels of proliferation markers with cell-protective properties support the neuroprotective effects of metformin, and these results are consistent with histological findings. |
27
References
Latency (s) to find the platform of Young, Young+Met, Aged, Aged+Met groups in MWM test.
25
20
15
10
5
0
**
Ag e d
#
Ag e d + M e t
ICP 2021 Outstanding Research Award Nominees Brief Reports
1.Valencia WM, Palacio A, Tamariz L, Florez H. Metformin and ageing: improving ageing outcomes beyond glycemic control. Diabetologia. 2017 Sep;60(9):1630-1638. doi: 10.1007/s00125-017-4349-5. Epub 2017 Aug 2.
2. Komsuoglu Celikyurt I et al. Exenatide Treatment Exerts Anxiolytic- and Antidepressant-Like Effects and Reverses Neuropathy in a Mouse Model of Type-2 Diabetes. Med Sci Monit Basic Res. 2014; 20: 112–117. Published online 2014 Jul 30. doi: 10.12659/MSMBR.891168.
3. Fatemi I, Khaluoi A, Kaeidi A, Shamsizadeh A, Heydari S, Allahtavakoli MA. Protective effect of metformin on D-galactose-induced aging model in mice. Iran J Basic Med Sci. 2018 Jan;21(1):19-25. doi: 10.22038/IJBMS.2017.24331.6071.
4. Bang E, Lee B, Park JO, Jang Y, Kim A, Kim S, Shin HS. The Improving Effect of HL271, a chemical derivative of metformin, a popular drug for type II diabetes mellitus, on aging-induced cognitive decline. Exp Neurobiol 2018 Feb;27(1):45-56. doi: 10.5607/en.2018.27.1.45. Epub 2018 Feb 12.
5. Zhang J, Lin Y, Dai X, Fang W, Wu X, Chen X. Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner. FASEB J. 2019 Jun;33(6):7748-7757. doi: 10.1096/fj.201802718R. Epub 2019 Mar 20.
60
40
20
0
* ***
Young Young+Met Aged Aged+Met
****
#
****
##
Day1 Day2 Day3 Day4
28
Y o u n g
Y o u n g + M e t
Time spent in the escape platform quadrants of Young, Young+Met, Aged, Aged+Met groups in MWM test
Tim e spend in escape platform 's quadrant (sec)
Latency (1-4 days)
50 40 30 20 10
0
ICP 2021 Outstanding Research Award Nominees Brief Reports
Y o u n g
Y o u n g + M e t
Ag e d
Ag e d + M e t
#
Ag e d + M e t
First day latency of Young, Young+Met, Aged, Aged+Met groups in the PA test
300
200
100
0
***
Ag e d
Y o u n g
Y o u n g + M e t
Retention latency of Young, Young+Met, Aged, Aged+Met groups in the PA test
2500 2000 1500 1000
500 0
Y o u n g
Y o u n g + M e t
Ag e d
Ag e d + M e t
Locomotor activity of Young, Young+Met, Aged, Aged+Met groups